Trial Profile
Phase II trial of Sorafenib combined with on-demand Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer stage C)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2013
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms STAB
- 02 Sep 2013 New trial record